Standpoint Research Downgrades Pfizer (PFE) to Sell
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| Pfizer Inc. (NYSE: PFE) | Delayed: 30.42 +0.57 (1.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.85 | 52 Week High | $37.39 | |||
| Open | $30.05 | 52 Week Low | $28.25 | |||
| Day High | $30.44 | P/E | 18.44 | |||
| Day Low | $29.88 | EPS | $1.65 | |||
| Volume | 28,700,522 | |||||
